<DOC>
	<DOCNO>NCT00878618</DOCNO>
	<brief_summary>The aim study evaluate pharmacokinetics , safety tolerability oral dose extended-release test- reference formulation AZD0837 healthy volunteer fast fed condition .</brief_summary>
	<brief_title>Pharmacokinetics Extended-Release Test- Reference Formulations AZD0837</brief_title>
	<detailed_description />
	<criteria>Healthy subject age 18 45 year inclusive Body mass index ( BMI ) 19 30 kg/m2 inclusive Body weight 50 100 kg inclusive Women must either postmenopausal , permanently sterilise , childbearing potential , must negative pregnancy test intake study medication use reliable form contraception participation study . Significant illness ( include ongoing history liver disease ) , trauma surgical procedure 2 week preentry visit first administration Investigational Product Clinical significant abnormality clinical chemistry , haematology urinalysis result include positive result screen test serum hepatitis B surface antigen , hepatitis C antibody HIV positive FHb result preentry History bleeding disturbance ( include extensive menstrual bleeding ) thrombotic disorder Clinically significant medical history , judge investigator , include psychiatric disorder severe allergy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>